StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.00 (0.00%)

Close on Nov 18, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2021 it was -C$6.06M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2021Dec 31, 2021-C$6.06M–
FY2020Dec 31, 2020-C$728.40K–
FY2019Dec 31, 2019-C$249.58K–

More XORTX Therapeutics figures

See a number that looks wrong?